|
|
CSF Therapeutics is developing a novel device to prevent neurological debilitation and death caused by diminished cerebral blood flow. This condition affects more than 10 million individuals in the US, and includes stroke and Alzheimer’s disease. Based on the research at Cleveland Clinic, CSF Therapeutics’ device is designed to increase cerebral blood flow indefinitely without affecting vascular or systemic function.
Funders:
Norwich Ventures
|
|
|